Christopher Kiritsy's Insider Trades & SAST Disclosures

Christopher Kiritsy's most recent trade in Palvella Therapeutics Inc. was a trade of 24,700 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 13, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Palvella Therapeutics Inc.
Christopher Kiritsy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2024 24,700 24,700 - - Stock Option (right to buy)
Pieris Pharmaceuticals Inc
Christopher Kiritsy Director Purchase of securities on an exchange or from another person at price $ 0.85 per share. 25 May 2023 10,000 20,000 (0%) 0% 0.9 8,500 Common Stock
Pieris Pharmaceuticals Inc
Christopher Kiritsy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Pieris Pharmaceuticals Inc
Christopher Kiritsy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 40,000 40,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades